Kennedy Capital Management »

Travere Therapeutics shares owned by Kennedy Capital Management

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Kennedy Capital Management from 13F filings

Historical chart of Kennedy Capital Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Kennedy Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Kennedy Capital Management

Quarter filed Position value Share count Share price at filing
2023-03-31 $5.6M 250k 22.49
2022-12-31 $6.0M 283k 21.03
2022-09-30 $4.1M 166k 24.64